Baker LD, Manson JE, Rapp SR, et al
What Drives the Cost Variation: Dosage, Purity, Sourcing, Stack Dosage and cycle length
A 2025 regulatory analysis by Hurley and Frier at Frier Levitt outlined the practical implications: legitimate medical access to many peptides continues, but the sourcing pathway matters more than ever, and the clinician's knowledge of the current regulatory status of each specific compound is a prerequisite for appropriate prescribing
Then, researchers made it stable enough for lab work
Ages & stages questionnaires [r], (asq-3 [tm]): A parent-completed child-monitoring system: Brookes Publishing Company, 2008